Invivyd (IVVD) Return on Sales Growth (1y) (2025)

Invivyd (IVVD) Return on Sales Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Nanobiotix 1,792.52 Bn 1,792.46 Bn - -
2 Akari Therapeutics 999.95 Bn 999.95 Bn - -
3 BeOne Medicines 475.97 Bn 471.17 Bn 1.35 Bn 0.00
4 Vertex Pharmaceuticals 124.91 Bn 117.66 Bn 2.59 Bn 0.00
5 Regeneron Pharmaceuticals 72.31 Bn 63.56 Bn 3.31 Bn 0.00
6 Belite Bio 62.01 Bn 62.01 Bn - -
7 Argenx Se 54.23 Bn 49.04 Bn 1.41 Bn 0.00
8 Alnylam Pharmaceuticals 38.31 Bn 35.30 Bn 959.66 Mn 0.00
9 Revolution Medicines 36.16 Bn 36.16 Bn - -
10 Invivyd 102.14 Mn -124.55 Mn 16.07 Mn 1.00

Historic Data

Download Data
DateValue
Dec 31, 2025 1.00
Sep 30, 2025 6.00
Jun 30, 2025 21.00